JDS (4190) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 佐登-KY

JDS (4190) reported revenue of NT$180.9 million for Oct 2026, -1.5% year on year and -6.7% from the previous month. Revenue for Jan–Oct 2026 was NT$1.77 billion (-4.7% year on year).

In Oct 2026, it ranked No. 47 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$184 million24/10Nov 2024 NT$194.7 millionDec 2024 NT$191.3 millionJan 2025 NT$211.6 millionFeb 2025 NT$179.4 million25/02Mar 2025 NT$210 millionApr 2025 NT$171 millionMay 2025 NT$174.8 millionJun 2025 NT$176.7 million25/06Jul 2025 NT$170.3 millionAug 2025 NT$164.6 millionSep 2025 NT$215.2 millionOct 2025 NT$183.7 million25/10Nov 2025 NT$198.8 millionDec 2025 NT$212.4 millionJan 2026 NT$207 millionFeb 2026 NT$138.3 million26/02Mar 2026 NT$208.9 millionApr 2026 NT$179.9 millionMay 2026 NT$177.8 millionJun 2026 NT$162 million26/06Jul 2026 NT$157.2 millionAug 2026 NT$162.9 millionSep 2026 NT$194 millionOct 2026 NT$180.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$180.9 million-1.5%-6.7%
Sep 2026NT$194 million-9.8%+19.1%
Aug 2026NT$162.9 million-1.0%+3.6%
Jul 2026NT$157.2 million-7.7%-2.9%
Jun 2026NT$162 million-8.3%-8.9%
May 2026NT$177.8 million+1.8%-1.1%
Apr 2026NT$179.9 million+5.2%-13.9%
Mar 2026NT$208.9 million-0.5%+51.0%
Feb 2026NT$138.3 million-22.9%-33.2%
Jan 2026NT$207 million-2.2%-2.6%
Dec 2025NT$212.4 million+11.0%+6.8%
Nov 2025NT$198.8 million+2.1%+8.2%
Oct 2025NT$183.7 million-0.2%-14.6%
Sep 2025NT$215.2 million+19.3%+30.7%
Aug 2025NT$164.6 million-17.3%-3.4%
Jul 2025NT$170.3 million-11.4%-3.6%
Jun 2025NT$176.7 million-3.8%+1.1%
May 2025NT$174.8 million-12.4%+2.2%
Apr 2025NT$171 million-11.9%-18.6%
Mar 2025NT$210 million+4.0%+17.0%
Feb 2025NT$179.4 million+12.9%-15.2%
Jan 2025NT$211.6 million+5.3%+10.6%
Dec 2024NT$191.3 million-26.5%-1.8%
Nov 2024NT$194.7 million-6.9%+5.9%
Oct 2024NT$184 million-20.5%+2.0%

Jan–Oct 2026 cumulative: NT$1.77 billion (-4.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: JDS vs PEC / JDS vs Lotus Pharm / JDS vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16